1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anterior Choroidal Artery Infarction

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Anterior Choroidal Artery Infarction in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	7 (70.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, HC; Chen, XM; Xu, ZR; Yang, YM	1
Anlar, O; Atbas, C; Tombul, T	1
Endo, S; Hirashima, Y; Kato, R; Ohmori, T; Takaku, A	1
Bourgain, R; Decuyper, K; van Rossem, K; Vermariën, H	1
Alp, MS; Aspey, BS; Harrison, MJ; Patel, Y	1
Adunsky, A; Atar, E; Bakoun, M; Hershkowitz, M; Poreh, A	1
Hiramoto, M; Imaizumi, T; Satoh, K; Takamatsu, S; Yoshida, H	1
Beck, T; Bielenberg, GW; Wagener, G	1
Akedo, Y; Kaku, S; Nagakawa, Y; Orimo, H	1
Joseph, R; Welch, KM	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anterior Choroidal Artery Infarction

Article	Year
Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study. Metabolic brain disease, 1997, Volume: 12, Issue:3 Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Combinations; Glutamic Acid; Leucine; Male; Movement Disorders; Neuroprotective Agents; Periaqueductal Gray; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium Channel Blockers; Time Factors	1997

Article

Year

Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study.

Metabolic brain disease, 1997, Volume: 12, Issue:3

Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Combinations; Glutamic Acid; Leucine; Male; Movement Disorders; Neuroprotective Agents; Periaqueductal Gray; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium Channel Blockers; Time Factors

1997

Other Studies

9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anterior Choroidal Artery Infarction

Article	Year
Creation of reversed phase high-performance liquid chromatographic technique to assay platelet-activating factor. Journal of Zhejiang University. Science, 2004, Volume: 5, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebral Infarction; Chromatography, High Pressure Liquid; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Reproducibility of Results; Sensitivity and Specificity	2004
Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; beta-Thromboglobulin; Biomarkers; Cerebral Infarction; Disability Evaluation; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Hemostatics; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Factor 4; Predictive Value of Tests; Risk Factors; Stroke	2005
Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. Journal of neurosurgery, 1994, Volume: 80, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Cerebral Infarction; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Rupture, Spontaneous; Subarachnoid Hemorrhage	1994
The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits. Advances in experimental medicine and biology, 1996, Volume: 388 Topics: Animals; Brain; Cerebral Infarction; Disease Models, Animal; Evoked Potentials, Somatosensory; Male; Neurons; Oxygen Consumption; Photobiology; Platelet Activating Factor; Pyridines; Rabbits; Thiazoles; Time Factors	1996
Infarct volume, neurological severity and PAF binding to platelets of patients with acute cerebral ischemic stroke. Neurological research, 1999, Volume: 21, Issue:7 Topics: Aged; Aged, 80 and over; Blood Platelets; Brain; Cerebral Infarction; Functional Laterality; Hemiplegia; Humans; Middle Aged; Paresis; Platelet Activating Factor; Reference Values; Tomography, X-Ray Computed	1999
Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta neurologica Scandinavica, 1992, Volume: 85, Issue:2 Topics: Aged; Cerebral Infarction; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phospholipids; Platelet Activating Factor; Radioimmunoassay	1992
Infarct reduction by the platelet activating factor antagonist apafant in rats. Stroke, 1992, Volume: 23, Issue:1 Topics: Animals; Azepines; Cerebral Infarction; Cerebrovascular Circulation; Platelet Activating Factor; Rats; Rats, Inbred F344; Triazoles	1992
Effect of nicergoline on platelet aggregation, plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction. Preliminary report. Arzneimittel-Forschung, 1990, Volume: 40, Issue:8 Topics: Aged; Arachidonic Acid; Arachidonic Acids; Blood Viscosity; Cerebral Infarction; Collagen; Erythrocyte Deformability; Female; Humans; Male; Middle Aged; Nicergoline; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors	1990
Granulocytes, platelet activating factor, and stroke. Stroke, 1989, Volume: 20, Issue:8 Topics: Animals; Cerebral Infarction; Granulocytes; Humans; Platelet Activating Factor	1989